Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Heteroplastic tissue grafting effected through roentgen-ray lymphoid destruction.JAMA. 1914; LXII: 1459
- The lymphocyte in immunology: from James B. Murphy to James L. Gowans.Nat Immunol. 2001; 2: 569-571
- The rejection of renal homografts. Inhibition in dogs by 6-mercaptopurine.Lancet. 1960; 1: 417-418
- The effects of 6-mercaptopurine on homograft reactions.J Clin Invest. 1960; 39: 952-958
- Prolonged survival of human-kidney homografts by immunosuppressive drug therapy.N Engl J Med. 1963; 268: 1315-1323
- The reversal of rejection in human renal homografts with subsequent development of homograft tolerance.Surg Gynecol Obstet. 1963; 117: 385-395
- Biological effects of cyclosporine A: a new antilymphocytic agent.Agents Actions. 1976; 6: 468-475
- Cyclosporine A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.Lancet. 1979; 2: 1033-1036
- Cyclosporine A in cadaveric organ transplantation.Br Med J (Clin Res Ed. 1981; 282: 934-936
- The use of cyclosporine A and prednisone in cadaver kidney transplantation.Surg Gynecol Obstet. 1980; 151: 17-26
- Liver transplantation with use of cyclosporine A and prednisone.N Engl J Med. 1981; 305: 266-269
- FK 506 for liver, kidney, and pancreas transplantation.Lancet. 1989; 2: 1000-1004
- Heart lung transplantation: successful therapy for patients with pulmonary vascular disease.N Engl J Med. 1982; 306: 557
- Technique of successful lung transplantation in humans.J Thorac Cardiovasc Surg. 1987; 93: 173
- Lung transplant immunosuppression - time for a new approach?.Expert Rev Clin Immunol. 2014; 10: 1419-1421
- Tolerance, immunosuppression, and immune modulation: impacts on lung allograft survival.Curr Opin Organ Transpl. 2021; 26: 328-332
- Mechanism of cellular rejection in transplantation.Pediatr Nephrol. 2010; 25: 61-74
- Immunosuppression for lung transplantation.Front Biosci (Landmark Ed. 2009; 14: 1627-1641
- B cell immunity in lung transplant rejection - effector mechanisms and therapeutic implications.Front Immunol. 2022; 13: 845867
- Germinal center Alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells.J Immunol. 2012; 188: 2643-2652
- T follicular helper cells in transplantation.Transplantation. 2016; 100: 1650-1655
- Regulatory immune cells in transplantation.Nat Rev Immunol. 2012; 12: 417-430
- T cell allorecognition pathways in solid organ transplantation.Front Immunol. 2018; 9: 2548
- Review: the transcripts associated with organ allograft rejection.Am J Transpl. 2018; 18: 785-795
- Advanced genomics-based approaches for defining allograft rejection with single cell resolution.Front Immunol. 2021; 12: 750754
- Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation.Sci Rep. 2022; 12: 7072
- The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match.J Heart Lung Transpl. 2019; 38: 1042-1055
- The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult lung and heart-lung transplant report-2018; focus theme: multiorgan transplantation.J Heart Lung Transpl. 2018; 37: 1169-1183
- The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation.Transpl Int. 2006; 19: 705-714
- Immunomodulation with rabbit anti-thymocyte globulin in solid organ transplantation.World J Transpl. 2015; 5: 261-266
- The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.Clin Transpl. 2008; 22: 603-608
- The impact of Alemtuzumab and Basliliximab Induction on patient survival and time to bronchitis obliterates syndrome in double lung transplantation recipients.Am J Transpl. 2016; 16: 2334-2341
- Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study.Am J Transpl. 2014; 14: 1839-1845
- Five-year outcomes with alemtuzumab induction after lung transplantation.J Heart Lung Transpl. 2011; 30: 743-754
- Alemtuzumab (Campath-1H): a systematic review in organ transplantation.Transplantation. 2006; 81: 1361-1367
- Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.Clin Infect Dis. 2007; 44: 204-212
- Antibody induction therapy for lung transplant recipients.Cochrane Database Syst Rev. 2013; 2013: CD008927
- A randomized, double-blind, placebo-controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation.Am J Transpl. 2014; 14: 1191-1198
- Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.Transpl Proc. 2009; 41: 1821-1824
- Tacrolimus and cyclosporinee have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.J Heart Lung Transpl. 2012; 31: 797-804
- Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study.Transpl Proc. 2010; 42: 4331-4337
- Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation.Transpl Int. 2011; 24: 666-675
- Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.Drug Des Devel Ther. 2013; 7: 1253-1258
- Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.Transpl Proc. 2011; 43: 2950-2953
- Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.Cochrane Database Syst Rev. 2015; 3: CD007746
- Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.Transplantation. 2001; 71: 1772-1776
- Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients.Transplantation. 2006; 81: 998-1003
- Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.J Heart Lung Transpl. 2018; 37: 853-859
- EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects.Fundam Clin Pharmacol. 2009; 23: 617-624
- How corticosteroids control inflammation: quintiles prize lecture 2005.Br J Pharmacol. 2006; 148: 245-254
- Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.Clin Pharmacokinet. 2012; 51: 711-741
- Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.Clin Biochem. 1998; 31: 335-340
- Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.Am J Respir Crit Care Med. 2011; 183: 379-387
- Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial.Am J Transpl. 2006; 6: 169-177
- Everolimus versus mycophenolate mofetil de novo after lung transplantation: a prospective, randomized, open-label trial.Am J Transpl. 2016; 16: 3171-3180
- Survival associated with sirolimus plus tacrolimus maintenance without induction therapy compared with standard immunosuppression after lung transplant.JAMA Netw Open. 2019; 2: e1910297
- Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.BMJ. 2014; 349: g6679
- Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.Am J Kidney Dis. 2006; 47: e67-e72
- Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression.J Heart Lung Transpl. 2004; 23: 632-638
- Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation.Transplantation. 2003; 75: 1437-1443
- Interstitial lung disease associated with mTOR inhibitors in solid organ transplant recipients: results from a large phase III clinical trial program of everolimus and review of the literature.J Transpl. 2014; 2014: 305931
- Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus.Transpl Proc. 2010; 42: 3050-3052
- Recommendations on the use of everolimus in lung transplantation.Transpl Rev (Orlando). 2013; 27: 9-16
- An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.Eur Respir J. 2014; 44: 1479-1503
- Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: a systematic review.J Heart Lung Transpl. 2017; 36: 921-933
- Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.Transplantation. 2012; 94: 101-109
- Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation.Transplantation. 2004; 77: 1465-1467
- Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.Am J Respir Crit Care Med. 2006; 174: 566-570
- Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.Transplantation. 2008; 85: 36-41
- Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?.J Heart Lung Transpl. 2010; 29: 1358-1368
- Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.Clin Transpl. 2014; 28: 906-910
- Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.J Heart Lung Transpl. 2010; 29: 531-537
- A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.Eur Respir J. 2011; 37: 164-172
- Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients.Transpl Proc. 2007; 39: 213-217
- Role for CD4 CD25 T cells in inhibition of graft rejection by extracorporeal photopheresis.J Heart Lung Transpl. 2008; 27: 616-622
- Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.Blood. 2008; 112: 1515-1521
- Extracorporeal photopheresis for bronchiolitis obliterans syndrome after lung transplantation.Transplantation. 2018; 102: 1059-1065
- Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.Transplantation. 2008; 86: 1625-1627.41
- The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.J Heart Lung Transpl. 2010; 29: 424-431
- A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.J Heart Lung Transpl. 2012; 31: 950-957
- Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: a 10-year single-centre analysis.Respiration. 2015; 90: 118-128
- Efficacy of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.Transpl Proc. 2017; 49: 695-698
- Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.Am J Transpl. 2013; 13: 911-918
- Total lymphoid irradiation as an immunosuppressive agent for transplantation and the treatment of 'autoimmune' disease: a review.Clin Radiol. 1985; 36: 125-130
- Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation.Int J Radiat Oncol Biol Phys. 1998; 41: 795
- The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation.Am J Transpl. 2005; 5: 537-543
- Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation.Transpl Proc. 2009; 41: 1816-1820
- Total lymphoid irradiation (TLI) for the management of bronchiolitis obliterans syndrome (BOS) post lung transplant: a single centre experience [abstract].J Heart Lung Transpl. 2016; 35: 70
- Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation: a single-center experience and review of literature.Transpl Int. 2020; 33: 216-228
- Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a randomized controlled trial.PLoS One. 2018; 13: e0193564
- Montelukast in chronic lung allograft dysfunction after lung transplantation.J Heart Lung Transpl. 2019; 38: 516-527
- Aerosolized cyclosporine in lung recipients with refractory chronic rejection.Am J Respir Crit Care Med. 1996; 153: 1451-1455
- Aerosol cyclosporine therapy in lung transplant recipients with bronchiolitis obliterans.Eur Respir J. 2004; 23: 384-390
- A randomized trial of inhaled cyclosporine in lung-transplant recipients.N Engl J Med. 2006; 354: 141-150
- A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.Am J Transpl. 2022; 22: 222-229
- A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation.ERJ Open Res. 2019; 5: 00167
- Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation.Am J Respir Cell Mol Biol. 2010; 43: 403-412
- A safety and tolerability study of thin film freeze-dried tacrolimus for local pulmonary drug delivery in human subjects.Pharmaceutics. 2021; 13: 717
- Aerosolized tacrolimus: a case report in a lung transplant recipient.Transpl Proc. 2010; 42: 3876-3879
- Graft-protective effects of the HMG-CoA reductase inhibitor pravastatin after lung transplantation--a propensity score analysis with 23 years of follow-up.Transplantation. 2011; 92: 486-492
- Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.Clin Transpl. 2018; 32https://doi.org/10.1111/ctr.13156
- Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation.Am J Transpl. 2019; 19: 2358-2365
- Pirfenidone: a potential therapy for progressive lung allograft dysfunction?.J Heart Lung Transpl. 2013; 32: 574-575
- Pirfenidone: a potential new therapy for restrictive allograft syndrome?.Am J Transpl. 2013; 13: 3035-3040
- Pirfenidone in restrictive allograft syndrome after lung transplantation: a case series.Am J Transpl. 2018; 18: 3045-3059
- Torquetenovirus: the human virome from bench to bedside.Clin Microbiol Infect. 2016; 22: 589-593
- Torque teno virus (TTV): current status.Rev Med Virol. 2007; 17: 45-57
- Temporal response of the human virome to immunosuppression and antiviral therapy.Cell. 2013; 155: 1178-1187
- Torque teno virus as a novel biomarker targeting the efficacy of immunosuppression after lung transplantation.J Infect Dis. 2018; 218: 1922-1928
- Viruses, friends, and foes: the case of Torque Teno Virus and the net state of immunosuppression.Transpl Infect Dis. 2022; 24: e13778
- A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial.Trials. 2014; 15: 324
- The "ABC" of virus-specific T cell immunity in solid organ transplantation.Am J Transpl. 2016; 16: 1697-1706
- Usefulness of immune monitoring in lung transplantation using adenosine triphosphate production in activated lymphocytes.J Heart Lung Transpl. 2012; 31: 996-1002
- Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients.Transpl Immunol. 2016; 37: 35-39
- Evaluation of Quantiferon®-Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients.Transpl Infect Dis. 2021; 23: e13550
- Evaluation of a novel global immunity assay to predict infection in organ transplant recipients.Clin Infect Dis. 2018; 66: 1392-1397
- Immunosuppression modifications based on an immune response assay: results of a randomized, controlled trial.Transplantation. 2015; 99: 1625-1632
- Viral load-guided immunosuppression after lung transplantation (VIGILung)-study protocol for a randomized controlled trial.Trials. 2021; 22: 48
- Antithymocyte globulin induction therapy improves survival in lung transplantation for cystic fibrosis.Transpl Int. 2013; 26: 34-41
- Survival benefit of induction immunosuppression in cystic fibrosis lung transplant recipients.J Cyst Fibros. 2015; 14: 104-110
- Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 ∗3/∗3 non-expressors.Transpl Immunol. 2006; 15: 235-240
- Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.Clin Pharmacokinet. 2010; 49: 141-175
- CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients.Springerplus. 2015; 4: 637
- Beyond single nucleotide polymorphisms: CYP3A5∗3∗6∗7 composite and ABCB1 haplotype Associations to tacrolimus pharmacokinetics in black and white renal transplant recipients.Front Genet. 2020; 11: 889
- Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance.Pharmacology. 2000; 61: 136-146
- Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity.Clin Transl Sci. 2022; 15: 859-865
- Lung transplantation in telomerase mutation carriers with pulmonary fibrosis.Eur Respir J. 2014; 44: 178-187
- Severe hematologic complications after lung transplantation in patients with telomerase complex mutations.J Heart Lung Transpl. 2015; 34: 538-546
- Strategies for the prevention of invasive fungal infections after lung transplant.J Fungi (Basel). 2021; 7: 122
- What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis.Am J Transpl. 2013; 13: 2601-2610
- A prospective observational study of hypogammaglobulinemia in the first year after lung transplantation.Transpl Direct. 2018; 4: e372
- Intravenous immunoglobulin for hypogammaglobulinemia after lung transplantation: a randomized crossover trial.PLoS One. 2014; 9: e103908
- Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality.Am J Transpl. 2005; 5: 1469-1476
- Severe acute kidney injury according to the RIFLE (risk, injury, failure, loss, end stage) criteria affects mortality in lung transplantation.J Heart Lung Transpl. 2011; 30: 1161-1168
- Acute renal failure following lung transplantation: risk factors, mortality, and long-term consequences.Eur J Cardiothorac Surg. 2012; 41: 193-199
- Short-term and long-term outcomes of acute kidney injury after lung transplantation.J Heart Lung Transpl. 2012; 31: 244-251
- Incidence and outcomes of acute kidney injury following orthotopic lung transplantation: a population-based cohort study.Nephrol Dial Transpl. 2014; 29: 1702-1709
- Kidney injury after lung transplantation: long-term mortality predicted by post-operative day-7 serum creatinine and few clinical factors.PLoS One. 2022; 17: e0265002
- Acute kidney injury increases mortality after lung transplantation.Ann Thorac Surg. 2012; 94: 185-192
- Dialysis after lung transplantation: prevalence, risk factors and outcome.J Heart Lung Transpl. 2007; 26: 1155-1162
- Renal disease in recipients of nonrenal solid organ transplantation.Semin Nephrol. 2007; 27: 498-507
- Recovery from AKI and short- and long-term outcomes after lung transplantation.Clin J Am Soc Nephrol. 2013; 8: 19-25
- Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury.Kidney Int. 2017; 92: 440-452
- Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity.Artif Organs. 2020; 44: 140-152
- Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: comparison of cyclosporine and tacrolimus eras.Transplantation. 2016; 100: 1723-1731
- Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: a single centre experience.PLoS One. 2019; 14: e0210443
- Basiliximab induction with delayed calcineurin inhibitors for high-risk lung transplant candidates.Yonsei Med J. 2021; 62: 164-171
- Anti-CD25 monoclonal antibody coverage allows for calcineurin inhibitor "holiday" in solid organ transplant patients with acute renal dysfunction.Transplantation. 2002; 73: 1169-1172
- Use of a "CNI holidays" strategy in acute renal dysfunction late after heart transplant. Report of two cases.Heart Int. 2014; 9: 74-77
- A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation.Am J Transpl. 2019; 19: 1759-1769
- Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial.Transpl Int. 2016; 29: 819-829
- Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation.Trials. 2021; 22: 6
- Belatacept for renal rescue in lung transplant patients.Transpl Int. 2016; 29: 453-463
- IgG endopeptidase in highly sensitized patients undergoing transplantation.N Engl J Med. 2017; 377: 442-453
- Imlifidase desensitization in crossmatch-positive, highly sensitized kidney transplant recipients: results of an international phase 2 trial (highdes).Transplantation. 2021; 105: 1808-1817
- Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients.Am J Transpl. 2021; 21: 3907-3918
- Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials.Expert Opin Emerg Drugs. 2022; 27: 151-167
- Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients.Clin Transpl. 2022; 36: e14734
- Interleukin-6, A cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade.Transplantation. 2017; 101: 32-44
- CD28 co-stimulation in T-cell homeostasis: a recent perspective.Immunotargets Ther. 2015; 4: 111-122
- A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).Am J Transpl. 2010; 10: 535-546
- Belatacept and long-term outcomes in kidney transplantation.N Engl J Med. 2016; 374: 333-343
- Belatacept for kidney transplant recipients.Cochrane Database Syst Rev. 2014; 2014: CD010699
- Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes.Nat Med. 2008; 14: 88-92
- Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.Blood Adv. 2019; 3: 3522-3538
- Precision engineering of an anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance.Front Immunol. 2021; 12: 686439
- A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.Hepatology. 2016; 64: 632-643
- Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.Hum Immunol. 2018; 79: 258-265
- Inducing transient mixed chimerism for allograft survival without maintenance immunosuppression with combined kidney and bone marrow transplantation: protocol optimization.Transplantation. 2020; 104: 1472-1482
- Tolerance and immunity after sequential lung and bone marrow transplantation from an unrelated cadaveric donor.J Allergy Clin Immunol. 2015; 135: 567-570
- The fourth international workshop on clinical transplant tolerance.Am J Transpl. 2021; 21: 21-31
- The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.Am J Transpl. 2021; 21: 3831-3839
- Cyclosporin A administration during ex vivo lung perfusion preserves lung grafts in rat transplant model.Transplantation. 2020; 104: e252-e259
- Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs.Sci Transl Med. 2022; 14: eabm7190
- Cyclosporin A Administration During Ex Vivo Lung Perfusion Preserves Lung Grafts in Rat Transplant Model.Transplantation. 2020; 104: e252-e259
- Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs.Sci Transl Med. 2022; 14: eabm7190
Article info
Identification
Copyright
Crown Copyright © 2022 Published by Elsevier Inc. All rights reserved.
